Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Goldgrub
Pcn21 - Comparative Efficacy of Nivolumab±ipilimumab Versus Standard of Care (Soc) for Third-Line (3l) Patients With Recurrent Small Cell Lung Cancer (Sclc) Using Population-Adjusted Indirect Comparison
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.04-29 Second or Third Line Nivolumab Versus First Line Nivolumab in Patients With Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.12-16 Significant Tumor Regression and Toxicity With Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Brain Metastases in Patients With Breast Cancer Versus Non–small Cell Lung Cancer: Comparison of an Unscreened Versus a Screened Population
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Efficacy of Nivolumab in Pre-Treated Non-Small-Cell Lung Cancer Patients Harbouring KRAS Mutations
British Journal of Cancer
Cancer Research
Oncology
Treatment Paradigms for Patients With Metastatic Non-Small-Cell Lung Cancer: First-, Second-, and Third-Line
Current Oncology
Oncology
Ipilimumab Combined With Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
Clinical Cancer Research
Cancer Research
Oncology
Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient With Small-Cell Lung Cancer
Case Reports in Neurological Medicine
